CRP and apparent mineralocorticoid excess: Additionally, Wanaratna’s 2022 study reported that, by day 5, a greater proportion of patients in the APE group achieved low serum CRP levels (≤10 mg/L) compared to the SC group (p = 0.02) (Wanaratna et al., 2022).